There is a need for effective and well-tolerated treatments that can be used in the early stages of dementia. Overall, the evidence suggests that taking a standardized, proprietary ginkgo extract may be an effective intervention for the primary and secondary prevention of cognitive impairment and mild to moderate dementia. To confirm the efficacy in patients with mild dementia, Riepe et al. conducted a meta-analysis.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
- Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy
Remodeling can be counteracted through a proactive treatment strategy
- From symptom to diagnosis
Gynecomastia and Adipomastia
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- SURPASS-CVOT
Tirzepatide versus Dulaglutide in T2D with ASCVD
- Secondary prevention after ACS: individually optimized lipid management
Trend towards early combination therapy and new strategies for lowering Lp(a)
- Pediatric Brain Tumors
Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
- What the latest studies on the entire EF spectrum mean for clinical practice
Heart Failure – The 2026 Evidence Update
- Acute ischemic stroke